NEW YORK (GenomeWeb) – DxTerity said today that it is collaborating with City of Hope Medical Center to develop a blood test to predict whether cancer patients are likely to benefit from radiation therapy or are at risk for radiation toxicity.
NEW YORK (GenomeWeb) – DxTerity said today that it is collaborating with City of Hope Medical Center to develop a blood test to predict whether cancer patients are likely to benefit from radiation therapy or are at risk for radiation toxicity.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.